Skip to content
Search

Latest Stories

Knights Pharmacy expands footprint in South Wales with acquisition of 2 new pharmacies

Knights Pharmacy expands footprint in South Wales with acquisition of 2 new pharmacies
Knights pharmacy to provide independent prescribing services at the new locations in South Wales

Knights Pharmacy has significantly expanded its footprint in South Wales through its recent acquisition of pharmacies in Abercarn and Cwmcarn from the Evans Group.

This move marks another strategic expansion for the Redditch-based pharmacy group, bolstered by funding from HSBC UK.


The Abercarn site, which handles approximately 12,000 medication items annually, and the Cwmcarn site, dispensing around 5,000 items, will now operate under the Knights Pharmacy banner.

This acquisition adds to Knights Pharmacy's growing portfolio, which now spans 49 community sites across England and Wales, a substantial increase from 18 sites just three years ago.

Anand Sodha, Managing Director at Knights Pharmacy, emphasised the company's commitment to enhancing local healthcare services.

"We‘ve successfully built our presence across the West Midlands and South Wales over the past number of years," said Sodha.

"Our plan for these two additional sites, and for the rest of our locations, is to focus on continually bettering our services.

"By offering vital treatment for minor ailments, we can help to alleviate the pressure on the NHS and ensure our customers receive the care they need," he added.

Knights Pharmacy intends to augment the Abercarn site by introducing a new treatment room, complementing its existing facilities.

The company also reaffirmed its commitment to providing independent prescribing services at both locations, empowering pharmacists to prescribe medications for minor illnesses.

Partho Bose, Relationship Director for West Midlands MME at HSBC UK, highlighted the alignment between Knights Pharmacy's growth strategy and HSBC's support for ambitious businesses.

"Knights Pharmacy’s commitment to community health and its vision for growth aligns with our goal of backing ambitious businesses," Bose noted.

"We look forward to seeing the positive impact these acquisitions will have on local communities in South Wales."

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less